Leukemia and therapy

American Journal of Immunology

Volumn 7, Issue 4, 2011, Pages 54-61

  Alitheen, N B ^a   Yeap, S K ^a   Faujan, N H ^a   Ho, W Y ^a   Beh, B K ^a   Mashitoh, A R ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

Cytotoxic; Leukemia; Natural products; Therapy

Indexed keywords

ANTHRACYCLINE; CYTARABINE; DAUNORUBICIN; ELEPHANTOPUS SCABER EXTRACT; GONIOTHALAMUS MACROPHYLLUS EXTRACT; IDARUBICIN; MICROMELUM MINUTUM EXTRACT; MITOXANTRONE; MORINDA ELLIPTICA EXTRACT; PLANT EXTRACT; RETINOIC ACID; TRITICUM AESTIVUM EXTRACT; UNCLASSIFIED DRUG; VERNONIA AMYGDALINA EXTRACT; ZINGIBER ZERUMBET EXTRACT;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE MEGAKARYOCYTIC LEUKEMIA; ACUTE MONOCYTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; CANCER CELL CULTURE; CANCER REGRESSION; CYTOTOXICITY; DRUG SAFETY; DRY SKIN; ELEPHANTOPUS SCABER; ERYTHROLEUKEMIA; GONIOTHALAMUS MACROPHYLLUS; HEADACHE; HUMAN; IMMUNOMODULATION; LEUKOCYTOSIS; MEDICINAL PLANT; MICROMELUM MINUTUM; MORINDA ELLIPTICA; PROMYELOCYTIC LEUKEMIA; PRURITUS; REVIEW; SIDE EFFECT; TRITICUM AESTIVUM; VERNONIA AMYGDALINA; XEROSTOMIA; ZINGIBER ZERUMBET;

EID: 84857932690     PISSN: 1553619X     EISSN: None     Source Type: Journal    
DOI: 10.3844/ajisp.2011.54.61     Document Type: Review

References (52)

1. Alitheen, N.B., S.K. Yeap, M. Shuhaimi, A. Abdul Manaf and A.R. Mashitoh et al., 2010. Cytotoxic effect of Damnacanthal, Nordamnacanthal, Zerumbone and Betulinic Acid isolated from Malaysian plant sources. Int. Food Res. J., 17: 711-719.
2. Alitheen, N.B., C.L. Oon, Y.S. Keong, T.K. Chuan and H.K. Li et al., 2011. Cytotoxic effects of commercial wheatgrass and fiber towards human acute promyelocytic leukemia cells (HL60). Pak. J. Pharm. Sci., 24: 243-250.
3. Al-Qubaisi, M., R. Rozita, S.K. Yeap, A.R. Omar and A.M. Ali et al., 2011. Selective cytotoxicity of goniothalamin against hepatoblastoma HepG2 cells. Molecules, 16: 2944-2959.
4. Alves, F., D.D.S. Rajao, H.L.D. Puerto, G.F. Braz and R.C. Leite, 2011. Occurrence of feline immunodeficiency virus and feline leukemia virus infection in cats. Am. J. Anim. Vet. Sci., 6: 125-129. DOI: 10.3844/ajavsp.2011.125.129
5. Anino, L., M.L. Vegna and A. Camera, 2002. Treatment of Adult Lymphoblastic Leukemia (ALL): Long-term follow up of the GIMEMA ALL 028 randomized study. Blood, 99: 863-871.
6. Ball, E.D. and A. Kagan, 2007. 100 Questions and Answers about Leukemia. 2nd Edn., Jones and Bartlett Learning, Sudbury, Mass., ISBN: 0763744980, pp: 125.
7. Becker, W.M., L.J. Kleinsmith and J. Hardin, 2000. The World of the Cell. 4th Edn., The Benjamin Cummings Publishing Co., Inc., California, ISBN: 0805308806, pp: 878.
8. Bennett, J.M., D. Catovsky, M.T. Daniel, G. Flandrin and D.A. Galton et al., 1985. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British cooperative group. Ann. Int. Med., 103: 620-625.
9. Catovsky, D., M. O'Brien and J.V. Melo, 1984. Hairy Cell Leukemia (HCL) variant: An intermediate disease between HCL and B prolymphocytic leukemia. Semin Oncol., 11: 362-369.
10. Collins, S.J., R.C. Gallo and R.E. Gallagher, 1977. Continuous growth and differentiation of human myeloid leukemic cells in suspension culture. Nature, 270: 347-349.
11. Darnell, J.E., H. Lodish, and D. Baltimore, 1986. Molecular cell Biology. 1st Edn., W.H. Freeman and Compony, New York, pp: 1036.
12. Evans, C.W., 1991. The Metastatic Cell: Behaviour and Biochemistry. 1st Edn., Chapman and Hall, London, New York, ISBN: 0412303000, pp: 555.
13. Faderl, S., M. Talpaz, Z. Estrov, S. O'Brien and R. Kurzrock et al., 1999. The biology of chronic myeloid leukemia. Nat. Engl. J. Med., 341: 164-172.
14. Faujan, N.H., N.B. Alitheen, S.K. Yeap, A.M. Ali and A.H. Muhajir et al., 2010. Cytotoxic effect of betulinic acid and betulinic acid acetate isolated from Malaysia plant on human myeloid leukemia (HL60) cell line. Afr. J. Biotechnol., 9: 6387-6396.
15. Fitri, S.Y.R., E.T. Atmodiwirjo and W. Wilman, 2011. Emotion regulation in childhood with cancer (acute lymphocytic leukemia). Am. Med. J., 2: 79-86. DOI: 10.3844/amjsp.2011.79.86
16. Gallagher, R., S. Collins, J. Trujillo, K. McCredie and M. Aheearn et al., 1979. Characterization of the continuous, differentiating myeloid cell line (HL- 60) from a patient with acute promyelocytic leukemia. Blood, 54: 713-733.
17. Gao, X., J. Kuo, H. Jiang, D. Deeb and Y. Liu et al., 2004. Immunomodulatory activity of curcumin: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity and cytokine production in vitro. Biochem. Pharmacol., 68: 51-61.
18. Golomb, H.M., A. Fefer and D.W. Golde, 1987. Sequential evaluation of alpha-2b-interferon treatment in 128 patients with hairy cell leukemia. Semin Oncol., 14: 13-17.
19. Gomathi, M. and P. Thangaraj, 2010. A computer aided diagnosis system for lung cancer detection\using support vector machine. Am. J. Applied Sci., 7: 1532-1538. DOI: 10.3844/ajassp.2010.1532.1538
20. Goodman, S.R., 2008. Medical Cell Biology. 3rd Edn., Academic Press, Amsterdam, ISBN: 0123704588, pp: 320.
21. Gustafsson, G., A. Kreuger, N. Clausen, S. Garwicz and J. Kristinsson et al., 1998. Intensified treatment of acute childhood lymphoblastic leukaemia has improved prognosis, especially in non-high-risk patients: The Nordic experience of 2648 patients diagnosed between 1981 and 1996. Nordic Society of Paediatric Heamatology and Oncology (NOPHO). Acta Paediatr, 87: 1151-1161.
22. Hanada, M., D. Delia, A. Aiello, E. Stadtmauer and J. Reed, 1993. Bcl-2 gene hypomethylation and highlevel expression in B-cell chronic lymphocytic leukemia. Blood, 82: 1820-1828.
23. Henderson, E.S. and E. Afshani, 1990. Clinical Manifestation and Diagnosis. Leukemia, Philadelphia, WB Saunders.
24. Ho, W.Y., H. Ky, S.K. Yeap, A.R. Raha and A.R. Omar et al., 2009. Traditional practice, bioactivities and commercialization potential of Elephantopus scaber Linn. J. Med. Plants Res., 3: 1212-1221.
25. Kingsley, E.C., B.G.M. Durie and H.S. Garewal, 1987. Acute Promyelocytic Leukemia. West J. Med., 146: 322-327.
26. Lee, S.J., K.H. Kim, J.S. Park, D.W. Kim and K.P. Kim, 2007. Comparative analysis of cell surface proteins in chronic and acute leukemia cell lines. Biochem. Biophys. Res. Comm., 357: 620-626.
27. Leonard, B., 1998. Leukemia: A Research Report. 2nd Edn., DIANE Publishing, ISBN: 0788171895, pp: 63.
28. Lodish, H., 2000a. Molecular Cell Biology. 3rd Edn., W.H. Freeman and Compony, New York, ISBN: 0716730537, pp: 1344.
29. Lowenberg, B., J.R. Downing and A. Burnett, 1999. Acute myeloid leukemia. Nat Engl. J. Med., 341: 1051-1062. DOI: 10.1056/NEJM199909303411407
30. Lowenberg, B., J.D. Griffin and M.S. Tallman, 2003. Acute myeloid leukemia and acute promyelocytic leukemia. Hematology, 1: 82-101. DOI: 10.1182/asheducation-2003.1.82
31. Matsuhisa, T. and Y. Mori, 1995. Mode of differentiation of human promyelocytic leukemia cell line, HL-60, by 1α,25-Dihydroxyvitamin D3. Blood Cell Mol. Dis., 28: 42-48.
32. Mattiuzzi, G.N., G. Alvarado, R. Alvarez, F. Giles, I. Lopez-Roman and E. Estey, 2003. Incidence of pulmonary infiltrates in patients with acute myelogenous leukemia and myelodysplastic syndrome undergoing induction chemotherapy: Retrospective analysis of 5 years. Proceedings of the Abstracts of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, (AAC' 03), American Society for Microbiology, Chicago, pp: 379-379.
33. Mazzotta, P., A. Kwasnicka and G.J. Kutas, 2001. Cancer chemotherapy: The role of pharmacological agents in the management of hematological malignancies. Univ. Toronto Med. J., 79: 38-45.
34. Melo, J.V. and C. Chuah, 2007. Resistance to imatinib mesylatate in chronic myeloid leukemia. Cancer Lett., 249: 121-132.
35. Mughal, T.I. and J.M. Goldman, 2001. Chronic myeloid leukaemia. STI 571 magnifies the therapeutic dilemma. Eur. J. Cancer, 37: 161-168.
36. Mughal, T.I. and J.M. Goldman, 2003. Chronic Myeloid Leukaemia. Eur. J. Cancer, 37: 561-568.
37. Pepper, C., P. Bentley and T. Hoy, 1996. Regulation of clinical chemoresistance by bcl-2 and baxoncoproteins in B-cell chronic lymphocytic leukemia. Br. J. Heamatol., 95: 513-517.
38. Pugazhenthi, D. and S.P. Rajagopalan, 2009. Unbalance quantitative structure activity relationship problem reduction in drug design. J. Comput. Sci., 5: 764-772. DOI: 10.3844/jcssp.2009.764.772
39. Rai, K.R., A. Sawitsky, E.P. Cronkite, A.D. Chanana and R.N. Levy et al., 1975. Clinical staging of chronic lymphocytic leukemia. Blood, 46: 219-234.
40. Ratanachoo, K., P.R. Gascoyne and M. Ruchirawat, 2002. Detection of cellular responses to toxicants by dielectrophoresis. Biochimica et Biophysica Acta., 1564: 449-458.
41. Saeed, B.A. and R.S. Elias, 2010a. Density functional theory based quantitative structure activity relationship study of 2,5-Bis(1-Aziridinyl)-pbenzoquinones with lymphoid leukemia. Am. J. Applied Sci., 7: 902-905. DOI: 10.3844/ajassp.2010.902.905
42. Sanz, M.A., G. Martin, C. Rayon, J. Esteve and M. Gonzalez et al., 1999. A modified AIDA protocol with anthracycline based consolidation results in high anti-leukemic efficacy and reduced toxicity in newly diagnosed acute promyelocytic leukemia. Blood, 94: 3015-3021.
43. Tallman, M.S., J.W. Andersen and C.A. Schiffer, 1997. All-trans retinoic acid in acute promyelocytic leukemia. Nat. Engl. J. Med., 337: 1201-1208.
44. Tallman, M.S., C.H. Nabhan, J.H. Feusner and J.M. Rowe, 2002. Acute promyelocytic leukemia: Evolving therapeutic strategies. Blood, 99: 759-767.
45. Tan, B.K., N.B. Alitheen, S.K. Yeap, A.M. Ali and R. Mawardi, 2009. Cytotoxic effect of 2',3'-epoxy isocapnolactone and 8-hydroxyisocapnolactone- 2'3'-diol isolated from Micromelum minutum (G.Forst.) Wight and Arn. in human T-lymphocyte leukemia CEM-SS cells. Afr. J. Biotechnol., 8: 4632-4641.
46. Valdivieso, F., C. Gimenez and F. Mayor, 1975. In vivo inhibition of rat liver phenylalanine hydroxylase by p-chlorophenylalanine and esculin: Experimental model of phenylketonuria. Biochem. Med., 12: 72-78.
47. Warrell, R.P. H. Jr., De The, Z.Y. Wang and L. Degos, 1993. Acute promyelocytic leukemia. Nat. Engl. J. Med., 329: 177-89.
48. Witz, F., A. Sadoun, M.C. Perrin, C. Berthou and J. Briere et al., 1998. A placebo-controlled study of recombinant human granulocyte-macrophage colony-stimulating factor administered during and after induction treatment for de novo acute myelogenous leukemia in elderly patients. Groupe Ouest Est Leucemies Aigues Myeloblastiques (GOELAM). Blood, 91: 2722-2730.
49. Yeap, S.K., N.B. Alitheen, S. Mustafa, A.S. Abdul and R.M. Abdul et al., 2010a. Immunomodulatory effects of zerumbone isolated from roots of Zingiber zerumbet. Pak. J. Pharm. Sci., 23: 75-82.
50. Yeap, S.K., W.Y. Ho, B.K. Beh, W.S. Liang and H. Ky et al., 2010b. Vernonia amygdalina, an ethnoveterinary and ethnomedical used green vegetable with multiple bio-activities. J. Med. Plants Res., 4: 2787-2812.
51. Yeap, S.K., N.B.M. Alitheen, W.Y. Ho, A.R. Omar and A.M. Ali et al., 2011. Immunomodulatory role of Rhaphidophora korthalsii methanol extract on human peripheral blood mononuclear cell proliferation, cytokine secretion and cytolytic activity. J. Med. Plants Res., 5: 958-965.
52. Yeap, S.K., A.R. Omar, A.M. Ali, W.Y. Ho and B.K. Beh et al., 2012. Immunomodulatory effect of Rhaphidophora korthalsii on natural killer cell cytotoxicity. Evid Based Complement Alternat Med., 2012, 786487.